Avantax Advisory Services’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$232K	Buy	2,220 +114	+5%	+$11.9K	﹤0.01%	2101
2025 Q1	$246K	Buy	+2,106	New	+$246K	﹤0.01%	1967
2020 Q4	–	Sell	-7,850	Closed	-$560K	–	960
2020 Q3	$560K	Buy	+7,850	New	+$560K	0.01%	750